[Abstract Only] Randomized Trial: Electrical vs. Pharmacological Cardioversion for Emergency Department Patients with Acute Atrial Fibrillation
2 Feb, 2020 | 20:11h | UTCElectrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial – The Lancet (link to abstract – $ for full-text)
Summary: Electrical vs Chemical Cardioversion in ED Patients With Atrial Fibrillation (RAFF2) – EMOttawa (free)
Related Study: Randomized Trial: Early vs. Delayed Cardioversion in Recent-Onset Atrial Fibrillation – New England Journal of Medicine (free study and commentaries)
Related Commentary on Twitter
Published in @TheLancet today, @EMO_Daddy et al. are at it again with the RAFF2 trial; showing immediate rhythm control in patients with acute atrial fibrillation is safe and effective.
Visual infographic below.
Summary: https://t.co/OyFeKjIyjc
Article: https://t.co/y983EWDOaK pic.twitter.com/22EofQFgnH— EM Ottawa (@emergmedottawa) January 31, 2020